TORONTO--(BUSINESS WIRE)--(PINKSHEETS: HRAL - News) HearAtLast Holdings Inc. is pleased to announce that it has finalized the next phase of its expansion plans. Wal-Mart Canada will include HearAtLast operations in additional supercentre and discount store locations, as HearAtLast continues its national expansion program. HearAtLast along with Wal-Mart Canada’s management strategically identify locations that are best suited demographically for their unique hearing aid dispensing model. The 2008 calendar year will see HearAtLast maintain its growth model within select Canadian Wal-Mart locations.
During 2007, HearAtLast added 14 additional clinics for a total of 15 locations within Wal-Mart Canada. 2008 has seen the addition of 6 clinics already, including their first stand alone clinic in Florida.
HearAtLast Holdings Inc. will continue to identify new store opportunities in Wal-Mart Canada. This will allow the company to strengthen their position and brand, in the clinical audiological field and retail dispensing market.
"The partnership and support from Wal-Mart Canada has afforded us a rapid and successful expansion, in an otherwise dormant industry. The pairing of Walter Gretzky and Wal-Mart has created a true retail brand for the under serviced hearing aid market,” stated Robert Oswald, President of HearAtLast Holdings Inc.
About HearAtLast
HearAtLast Holdings, Inc. is a Nevada corporation that owns and operates its wholly-owned subsidiary HearAtLast Inc., a chain of hearing stores specializing in the sale of digital hearing aids and testing services. The company develops, owns, and operates hearing aid clinics located within select Wal-Mart stores throughout Canada. HearAtLast facilities sell a selection of high quality brand name hearing aids and also offer complimentary screening tests, clinical hearing tests, instant custom MP3 headphones and custom hearing protection. The Company’s mission is to consolidate the highly fragmented hearing services industry while providing unparalleled service to the estimated 30+ million hearing impaired individuals throughout North America. After a prescription is approved, the independent on-site audiologists and hearing aid practitioners at HearAtLast utilize a refined process to dispense a hearing aid in about an hour.
For more information please visit www.hearatlast.com
Safe Harbor
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.
The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment